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Background: Sled dogs commonly suffer from diarrhea. Although multiple etiologies exist there are limited field
studies using synbiotics as a supplement to prevent or treat diarrhea. The objective of this study was to examine
alterations in fecal quality, short-chain fatty acids (SCFA), and the fecal microbiome in two groups of training sled
dogs fed a synbiotic or microcrystalline cellulose placebo. Twenty clinically healthy training sled dogs randomized
into two cohorts (9 synbiotic-fed, 8 placebo-fed) for a 6 week prospective study were examined. Fecal pH and fecal
short chain fatty acid (SCFA) concentrations were measured and tag-encoded FLX 16S rDNA amplicon pyrosequencing
(bTEFAP) and quantitative real-time PCR were performed at baseline (10 d prior to the study) and after 2 weeks of
treatment with a total treatment time of 6 weeks. Fecal scores for all dogs were assessed at baseline and every day for
6 wk after initiation of treatment.
Results: Alterations in the fecal microbiome were observed with a significant rise in Lactobacillaceae in the synbiotic
group (P = 0.004) after 2 wk of treatment. A positive correlation was found between Lactobacillaceae and overall
butyrate concentration (R = 0.62, p = 0.011) in all dogs. After 5 wk of treatment, there was an improved fecal score and
fewer days of diarrhea (Χ2 = 5.482, P = 0.019) in the dogs given synbiotic, which coincided with a presumed contagious
outbreak shared by all dogs in the study.
Conclusions: Use of this synbiotic results in an increase in presumed beneficial bacterial flora of the host colon which
was associated with a decrease in the prevalence of diarrhea in training sled dogs.
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The high prevalence of diarrhea in sled dogs during ath-
letic events has caused researchers to investigate the eti-
ology, with limited results. Previous reports state 7.5%
morbidity in long-distance racing sled dogs; however, anec-
dotally the problem occurs with much greater frequency,
and diarrhea represents a leading cause for discontinued ra-
cing during distance racing events [1]. Salmonella spp. have
been suspected to be a contributor to the problem since* Correspondence: jw37@cornell.edu
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reproduction in any medium, provided the orsled dogs are known to consume raw diets, yet previous
studies in Alaskan sled dogs have demonstrated no as-
sociation between the isolation of Salmonella and clin-
ical diarrhea [2]. Other enteropathogens have been
implicated including Clostridium perfringens and Clos-
tridium difficile in companion dogs [3]. A recent study
refutes this suspicion as there was no association be-
tween the two species of clostridium or their respective
toxins and the presence of diarrhea in sled dogs [4]. Viral
etiologies have also been investigated with recent work
examining canine parvovirus in sled dogs competing in
the 2006 Iditarod Trail Race; however the titers did not
correlate to clinical manifestations [5]. Additionally, diar-
rhea has been associated with mental and physical stress
which can effect gastrointestinal permeability and motilityLtd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and is the prevailing theory surrounding much of the diar-
rhea observed in racing sled dogs, but has yet to be defini-
tively proven as the cause.
While clinical and field investigations into causes of diar-
rhea in sled dogs have not revealed a definitive pathogen,
dietary alterations are often used to manipulate the content
and consistency of feces in companion animals. Previous
studies have demonstrated the clinical benefits of probio-
tics include: inhibiting proliferation of pathogenic bacteria,
protecting the intestinal barrier, preventing gut bacterial
translocation to blood and distant sites, and modulating
immune function [7]. Probiotics have been used in veterin-
ary medicine for a number of years and have been reported
to significantly improve fecal scores in dogs with naturally
occurring diarrhea [8-10]. They are defined as dietary sup-
plements that contain viable non-pathogenic microorgan-
isms, which are considered to confer health benefits to the
hosta. The typical microorganisms used as probiotics are
lactic acid bacteria that are normal inhabitants of the co-
lonic flora and include strains of Enterococcus, Streptococ-
cus, Bifidobacterium, and Lactobacillus spp. These bacteria
have a history of safe use in humans and animals, and are
approved by the Association of American Feed Control
Officials (AAFCO).
Prebiotics (primarily soluble fiber) have been used to
alter the gut microbiome and quality of feces in multiple
species [11-13]. The proposed advantages of prebiotics
are that they are metabolized by the selected bacterial
species of the colon [14]. A variety of compounds may
act as prebiotics, but the great majority of them come in
the form of fiber and are typically oligosaccharides. Fer-
mentation by the colonic bacteria of these compounds
(specifically the Lactobacillus genera) will generate SCFAs
including acetate, propionate, and butyrate that may act as
a preferred fuel source for the colonocytes [15]. Some pre-
biotics (galactooligosaccharide) appear to exert a direct
antimicrobial effect by adhering to the binding sites on
the enterocyte surface and blocking the adhesion of patho-
genic bacteria to intestinal epithelial cells [16,17].
A synbiotic is a combination of a probiotic(s) and pre-
biotic(s). Synbiotics are designed not only to introduce
beneficial bacterial populations, but also to promote pro-
liferation of autochthonous-specific strains in the intes-
tinal tract [18]. To date, little research has been performed
using synbiotics in companion animals. The objectives of
the current study were to feed a synbiotic and a placebo
to two groups of sled dogs being exposed to identical diet-
ary substrate and environmental conditions during peak
training for competitive racing. We hypothesized that this
would result in an increased amount of SCFA production
that would increase colonic health, thereby resulting in
improved fecal quality and potentially decrease the epi-
sodes of diarrhea in training sled dogs.Methods
Study population
This study was approved by the Cornell University Insti-
tutional Animal Care and Use Committee. All dogs en-
rolled in the study underwent a physical examination,
complete blood count, and serum biochemistry panel.
Twenty healthy, normal Alaskan Husky dogs between
22–26 kg were enrolled in the study and any dogs with
elevated white blood cell counts or signs of organ dys-
function were excluded. Dogs were between the ages of
2 and 6 yr old, including 10 intact males and 10 intact
females. All dogs were housed in individual outdoor
kennels, with all dogs being kept on a clay dirt surface
that was cleaned twice daily.
Twenty dogs were randomly assigned to one of two
groups by designating one dog from each gender matched
pair to either treatment or placebo groups based on a coin
flip. Dogs were kenneled individually, but were not segre-
gated to treatment groups during training runs or travel,
allowing dog interactions between the two groups. All
dogs trained 3–4 times a week, running between 6–12
miles in upstate in the Lowville, New York, USA area.
Dogs were in training throughout the entire time of the
study and traveled to two races during the study. The dogs
traveled to Kalkaska, MI, USA on the weekend of January
16th and 17th just prior to initiation of the study and then
on February 14th and 15th to Mannsville, NY, USA. Daily
fecal scoring for each dog was performed by the same au-
thor (DAB) beginning on January 18th for 10 d to estab-
lish a baseline fecal score. Treatment was blinded whereby
dogs received either 5 g of synbioticb or 5 g of placebob
from pails labeled “1” and “2” respectively. The powdered
synbiotic or placebo was mixed into the dogs daily feed
between 9 and 11 a.m. every morning for 6 wk beginning
on January 28th, 2010.
Food and supplement analysis
All dogs were fed the same diet. The ration contained a
mix of two canine dry pet products with a 5:1 volume
ratio of the kibblec to the dry powderd (Additional file 1),
mixed with less than 20% volume/volume of ground beef.
The feed mixture was analyzed for crude protein, crude
fat, moisture, and crude fiber by Dairy One Analytical
Services (Ithaca, NY). Upon analysis, the ration was 46%
crude protein, 32% crude fat, 7% ash, 3% crude fiber on
a dry matter basis and approximately 5.2 kcal ME/g. Sam-
ples of the raw meat were also swab cultured and sent
to Cornell University Animal Health Diagnostic Center
Laboratory for anaerobic and aerobic culture of selected
microbial organisms for Salmonella, Campylobacter, and
E. coli. A standard aerobic microbial culture and enrich-
ment of the synbiotic and placebo was performed by the
Cornell University Diagnostic Laboratory to ensure viabil-
ity of organisms, before and immediately after the study.
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mg/g; 5.67 × 108 CFU/g), Bacillus coagulans (2.5 mg/g;
3.75 × 107 CFU/g), Lactobacillus acidophilus (14.4 mg/g;
7.2 × 108 CFU/g), fructooligosaccharides (400 mg/g),
mannanoligosaccharides (80 mg/g), Vitamin B1 (2.5 mg/g),
Vitamin B2 (0.8 mg/g), Vitamin B3 (19.2 mg/g), Vitamin B6
(0.8 mg/g), brewer’s yeast (80 mg/g), soy lecithin (30 mg/g),
magnesium stearate (10 mg/g), microcrystalline cellulose
(266 mg/g), mono-and diglyceraldehyde (30 mg/g), and
silica dioxide (7 mg/g). The placebo contained mi-
crocrystalline cellulose (629 mg/g), brewer’s yeast
(190 mg/g), soy lecithin (71 mg/g), magnesium stearate
(24 mg/g), mono-and diglyceraldehyde (71 mg/g), and
silica dioxide (16 mg/g).Fecal collection and scoring
Daily fecal scoring was performed (DAB) as an average
of feces observed on a daily basis during kennel clean up
and recorded. All feces were collected from every dog
over a 2 d period on days 9 and 10 of fecal scoring and
the mean of each dog was determined (baseline), prior
to initiation of the supplementation with feces being col-
lected within 5 min of defecation and immediately fro-
zen at -20°C. Feces were also collected and immediately
frozen from all dogs over a 2 d period 2 wk after initi-
ation of the synbiotic or placebo treatments. All fecal
samples were transported frozen to the laboratory within
2 wk of collection for pH testing and selective culturing
utilizing culture swabs with immediate plate streaking
for Salmonella spp. and Campylobacter spp. Giardia test-
ing was performed on all fecal samples using SNAP ELISA
kits. Fecal quality was assessed for every defecation by
using a 5-point visual scale, ranging from 1 (hard and dry
feces) to 5 (liquid diarrhea) [19]. A score of 2 represented
a well-formed stool that was easy to collect but was not
too dry; this was considered optimum. A daily score was
tallied based on the average score of all feces for that day.
Due to the propensity for contagious or other diarrhea
outbreaks occurring after initiation of training and racing,
the daily mean fecal scores from Sunday to Sunday were
averaged and presented as an average fecal score for each
week per group. The weekly average fecal scores were
then subtracted from the average fecal score before the
study began (baseline score) to provide an average change
in score for each dog (with positive trends being worse),
as the fecal scores at baseline were considered to be nor-
mal fecal consistency for that 10 day period according to
the kennel owner (DAB). Fecal scoring was further catego-
rized into normal (scores 1–3), or diarrhea (4 and 5) dur-
ing weeks where significant differences were detected
between groups to define whether diarrhea was being de-
tected at a greater rate, defined as days of diarrhea within
each week for each dog.Fecal pH and SCFA analysis
Fecal pH and SCFA was determined for each dog at
baseline and after 2 wk of treatment. Fecal pH was per-
formed by taking 2 g of the thawed fecal samples and
mixing with 1 part water to 1 part feces using a Mettler
Toledo InLab® Expert Pro PH meter. Fecal SCFA were
quantified by adding a 1 g portion of a fecal sample to 4
mL of water and 1 mL of 25% m-phosphoric acid, mixed
well, and allowed to precipitate for 30 min, then centrifuged
at 20,000× g for 20 min. The supernatant was decanted and
frozen at −80°C in microfuge tubes. After freezing, the
supernatant was thawed and centrifuged in microfuge tubes
at 10,000× g for 10 min. Concentrations of acetate, propion-
ate, and butyrate were determined in the supernatant using
a Hewlett-Packard 5890A series II gas chromatograph (Palo
Alto, CA) and a glass column (180 cm× 4 mm id) packed
with 10% SP-1200/1% H3PO4 on 80/100+ mesh Chromo-
sorb WAW (Supelco Inc., Bellefonte, PA). Oven temper-
ature, detector temperature, and injector temperature were
125, 175, and 180°C. Short-chain fatty acid concentration
values also were corrected for blank tube production of
SCFA. The supernatants were analyzed using the spectro-
photometric method described by Barker and Summerson
[20]. All samples were run in duplicate and an error no
greater than 5% was considered acceptable.
Fecal DNA extraction and bTEFAP
Samples were homogenously mixed after initial thawing
and 5 g of feces were shipped on ice overnight to the Re-
search and Testing Laboratory (Lubbock, TX, USA) for
Tag-encoded FLX 16S rDNA amplicon pyrosequencing
(bTEFAP). Fecal samples were homogenized and 200 mg
aseptically suspended in 500 μl RLT buffer (Qiagen,
Valencia, CA, USA) (with β-mercaptoethanol). A sterile 5
mm steel bead (Qiagen, Valencia, CA, USA) and 500 μl
volume of sterile 0.1 mm glass beads (Scientific Industries,
Inc., NY, USA) were added for complete bacterial lyses in a
Qiagen TissueLyser (Qiagen, Valencia, CA, USA), and run
at 30 Hz for 5 min. Samples were centrifuged and 100 μl
of 100% ethanol added to a 100 μl aliquot of the sample
supernatant. This mixture was added to a spin column,
and DNA recovery protocols were followed as instructed
in the Qiagen DNA Stool Kit (Qiagen, Valencia, CA, USA)
starting at step 5 of the protocol. DNA was eluted from
the column with 50 μl water and samples were diluted ac-
cordingly to a final nominal concentration of 100 ng/μl.
DNA samples were quantified using a Nanodrop spectro-
photometer (Nyxor Biotech, Paris, France). Once the DNA
was isolated the bTEFAP methodology was instituted to
examine the universal bacterial diversity within the feces. A
100 ng (1 μl) aliquot of each samples’ DNA was used for a
50 μl PCR reaction. The 16S universal Eubacterial primers
530 F (5′-GTG CCA GCM GCN GCG G) and 1100R (5′-
GGG TTN CGN TCG TTG) were used for amplifying the
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Mix Kit (Qiagen, Valencia, CA, USA) was used for PCR
under the following conditions: 94°C for 3 min followed by
32 cycles of 94°C for 30 sec; 60°C for 40 sec and 72°C for 1
min; and a final elongation step at 72°C for 5 min. A sec-
ondary PCR was performed for FLX (Roche, Nutley, NJ,
USA) amplicon sequencing under the same condition by
using designed special fusion primers with different tag se-
quences as: LinkerA-Tags-530 F and LinkerB-1100R. The
use of a secondary PCR prevents amplification of any po-
tential bias that might be caused by inclusion of tag and
linkers during initial template amplification reactions. After
secondary PCR, all amplicon products from different sam-
ples were mixed in equal volumes, and purified using
Agencourt Ampure beads (Agencourt Bioscience Corpor-
ation, Danvers, MA, USA).
Fecal DNA extraction and quantitative real-time PCR
To confirm bTEFAP results and to examine species that
were not included in bTEFAP, quantitative changes in
fecal abundance of Bifidobacteria, Lactobacillus, and En-
terococcus spp. in all dogs from baseline to 2 wk after
treatment was assessed. Bacterial DNA was extracted
using a PowerSoil DNA isolation kit (Mo Bio Laborator-
ies, Carlsbad, CA, USA) based on the manufacturer′s
protocol. Fecal DNA was quantified using a GE Nano-
Vue spectrophotometer (GE Healthcare, Buckinghamshire,
UK). Extracted DNA was diluted to 5 ng/μl. Quantitative
real-time PCR using bacterial universal and genus-specific
primers to generate standard curves and data for each gen-
era (Lactobacillus jonhsonii- ATCC - 53672, Bifidobacter-
ium animalis ATCC −700541, Enteroccus faecium –ATCC
BAA- 2320) were performed using SYBR Green-based as-
says (Applied Biosystems, Carlsbad, CA) and protocols as
described in Mazcorro, et al. [21]. Using a commercial
real-time PCR thermocycler (StepOnePlus; Applied Biosys-
tems, Carlsbad, CA, USA).
Statistical analysis
After examining quantile plots and Shapiro-Wilk testing,
it was determined that much of the microbiota and SCFA
data were not normally distributed; hence Wilcoxon Signed
Rank testing was used for statistical analysis before and
after treatment for pH, fecal scoring, percent microbial flora
change, and SCFA concentrations. Chi-square analysis was
performed to compare days of diarrhea between the pla-
cebo and synbiotic groups during each week of the trial. A
linear regression analysis was performed for each significant
family of bacteria to each SCFA and total SCFA at baseline
and 2 wk after treatment for all dogs. An operational taxo-
nomic unit was considered significant if it populated more
than 1% of the entire flora in a fecal sample, and thus was
included in the analysis of percentage change associated
with treatment as well as assessed in linear regressionanalysis against SCFA production. For all statistical analyses
the α was set at P ≤ 0.05. All statistical analyses were per-
formed using SigmaPlot 11.0e.
Results
Dogs and supplement analysis
Three dogs were excluded from the study due to acute
injuries during training resulting in 17 dogs completing
the study (9 dogs receiving synbiotic and 8 dogs receiv-
ing placebo). Anaerobic and aerobic microbial culturing
of the raw meat resulted in no organism growth (< 100
CFU/50 cm2). Initial microbial analysis showed viable or-
ganisms in the synbiotic at baseline, before implementing
treatment. At the end of the trial, only Enterococcus spp.
could be cultured from the synbiotic supplement.
Fecal pathogens, pH, scores, and SCFA analyses
No pathogens were isolated from aerobic microbial plate
streaking for Salmonella spp. or Campylobacter spp..
Giardia SNAP tests revealed only one positive in the
probiotic group in January. No significant difference in
fecal pH was observed between the two groups (P =
0.33). Initial average fecal scores for placebo and synbio-
tic groups were 2.91 ± 0.22 and 3.08 ± 0.24 respectively,
out of the 5 point scale. As a comparison, the mean dif-
ferences (and standard deviation) from baseline fecal
score to the end of each week is depicted in Figure 1. A
statistically significant difference between the two groups
(P = 0.02) was observed between weeks 4 and 5 of treat-
ment. When examined as total days of diarrhea between
the two groups, the synbiotic group showed significantly
fewer days of diarrhea than the placebo group (synbiotic
group - 6 d; total of 3 dogs; Cider, Marten, Thistle; average
duration 2 days); placebo group (17 d total of 4 dogs;
Sunny, Raven, Nimbus, Booty; average duration 4 days;
Χ2 = 5.482, P = 0.019) which coincided with a presumed
contagious outbreak in the kennel. No change (P > 0.05)
in acetate, propionate, or butyrate concentrations oc-
curred within the synbiotic or placebo groups or between
the two groups (data not shown). A linear regression ana-
lysis comparing significant microbial families (any family
comprising 1% or more of entire fecal microbiome) to in-
dividual and total SCFA in feces revealed a positive cor-
relation between Lactobacillaceae and overall butyrate
concentration (R = 0.62, P = 0.011).
Fecal microbiota
There were no significant differences in fecal bacterial
populations between the synbiotic and placebo groups
before treatment. Within the group receiving synbiotic
(Table 1), bTEFAP results from fecal samples after 2 wk of
treatment showed an increase in Lactobacillaceae (P =
0.004), and decreased Clostridiaceae (P = 0.004), Erysipelo-






































Figure 1 Mean weekly change and standard deviation in group fecal scores from baseline for 6 weeks after initiation of placebo or
synbiotic treatment. Initial mean score for placebo was 2.91 and 3.06 for synbiotic. *indicates a p < 0.05 for the indicated time point.
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samples after 2 wk of treatment showed decreases in Clos-
tridiaceae (P = 0.008), Ruminococcaceae (P = 0.008), Erysi-
pelotrichaceae (P = 0.008), and Eubacteriaceae (P = 0.039)
from baseline. When comparing percentage changes (of the
significant microbial families represented in Tables 1 and 2)
from baseline to after 2 wk of treatment between the two
groups, the only microbial family demonstrating statisticalTable 1 Percent (medians and ranges) of microbial families co
synbiotic-fed dogs at baseline and after 2 wk of treatment ba

















Enterococcaceae 0.27 (0.00-2.99)significance was Lactobacillaceae (P = 0.039). A dual hier-
archical clustering dendrogram of the 50 most abundant
bacterial families created from the bTEFAP data indicated
as a definite stratification into two microbiome populations
based on a time (January vs. February) with a few outliers
at each time point. There also appears to be a tighter clus-
tering of dogs in February that were synbiotic-fed (as indi-
cated by S in the February group) except for a singlemprising 1% or more of the microbiota in the feces of
sed on bTEFAP analysis
Synbiotic group (n = 9) Synbiotic group (n = 9)

















Table 2 Percent (medians and ranges) of microbial families comprising 1% or more of the microbiota in the feces of
placebo-fed dogs at baseline and after 2 wk of treatment based on bTEFAP analysis
Microbial family Placebo group (n = 8) Placebo group (n = 8) Placebo group (n = 8)
% at baseline % after 2 wk of treatment P-value
Lactobacillaceae 6.08 (2.90-33.41) 16.40 (0.81-51.34) 0.461
Clostridiaceae 38.26 (10.25-52.29) 3.86 (0.97-28.65) 0.008
Erysipelotrichaceae 3.66 (0.53-13.18) 0.71 (0.11-6.20) 0.008
Eubacteriaceae 1.90 (0.80-3.03) 0.25 (0.05-2.14) 0.039
Streptococcaceae 4.67 (0.61-29.90) 15.35 (5.30-61.93) 0.109
Ruminococcaceae 12.46 (5.88-20.03) 3.07 (0.47-15.01) 0.008
Bacteroidaceae 0.31 (0.00-1.00) 1.23 (0.14-4.01) 0.109
Alcaligenaceae 0.07 (0.00-0.70) 0.15 (0.02-3.18) 0.383
Leuconostocaceae 0.20 (0.06-1.89) 0.05 (0.00-0.30) 0.078
Prevotellaceae 0.40 (0.00-0.89) 0.52 (0.05-23.98) 0.313
Lachnospiraceae 0.54 (0.06-1.99) 0.36 (0.04-0.71) 0.148
Enterobacteriaceae 0.26 (0.02-2.27) 0.07 (0.02-20.01) 0.547
Coriobacteriaceae 1.06 (0.37-1.52) 0.48 (0.05-2.00) 0.461
Fusobacteriaceae 0.00 (0.00-3.45) 0.81 (0.00-28.37) 0.109
Succinivibrionaceae 0.09 (0.00-0.33) 0.07 (0.00-1.02) 0.945
Enterococcaceae 0.09 (0.00-0.60) 0.02 (0.00-0.16) 0.148
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ation segregates on both time and treatment groups
(Figure 2).
Quantitative real-time PCR
Analysis by qPCR comparing baseline to 2 wk after treat-
ment, demonstrated a statistically significant increase in
the abundance of Lactobacillus (P = 0.02) and Bifidobac-
teria spp. (P = 0.008) in feces of the synbiotic-fed dogs,
which was not observed in the placebo-fed dogs. Fecal
abundance of Enterococcus spp. was not significant differ-
ent when comparing these same time points in both
groups (Tables 3 and 4).
Discussion
Probiotics and prebiotics have been purported to have
many beneficial effects on the microbiome of the gastro-
intestinal tract and immune system of multiple species
[11,22-26]. Our results from the 6 wk study period indi-
cate beneficial effects from the use of both a prebiotic
and probiotic in combination. The clinical evidence shows
that fewer days of diarrhea during a presumed contagious
outbreak was observed during wk 5 of treatment. This
may be attributed to a microbiome shift of the phylum
Firmicutes favoring an increase in Lactobacillus spp. The
microbiome shift was also represented in the phylum
Actinobacteria including an increase in Bifidobacterium
spp. These shifts may result in production of SCFA such
as butyrate and therefore favor enterocyte health and re-
generation [15]. Unfortunately, at the end of the 6 wk oftreatment, neither Lactobacillus or Bacillus spp. could be
cultured from the synbiotic and therefore, did not appear
to colonize the gut effectively. Enterococcus faecium SF68
was not included in our bTEFAP microbial analysis; how-
ever quantitative real-time PCR results demonstrated a
sparse population of Enterococccus spp. and no signifi-
cant increase or decrease in either the synbiotic or
placebo-fed groups.
The lack of long-term viability of bacterial strains in
the synbiotic formulation was not surprising. A recent
evaluation of 25 commercially available products for
label accuracy and bacterial content revealed that the
overall level of bacterial growth was highly variable, with
one product having no viable growth despite its labeling
of 14 million CFU/capsule, and another product contain-
ing greater than the stated concentration of Bifidobacter-
ium animalis [27]. Use of a similar synbiotic containing
Bifidobacterium, Enterococcus, Streptococcus, and four dif-
ferent strains of Lactobacillus spp. in dogs showed that
only Enterococcus and Streptococcus counts increased sig-
nificantly in the feces of dogs and that the Lactobacillus
and Bifidobacterium spp. did not colonize effectively [21].
Our findings suggest significant rises in Lactobacillus
and Bifidobacterium spp, which is contradictory to this
previous synbiotic study [21]. In the previous study the
synbiotic used a 500 mg capsule containing similar num-
ber of probiotic as our synbiotic, but significantly less pre-
biotic. Dogs in the study were client owned dogs weighing
between 10 and 80 lbs. The amount of prebiotic supplied
in the diet presumably ranged between approximately
Figure 2 Dual hierarchical clustering dendrogram of the 50 most abundant bacterial families of all dogs (n = 17) at the January and
February samplings showing grouping based on time of sampling and clustering of dogs on the synbiotic (designated with S below
their names) in the February sampling that is not observed in the January sampling (S designated dogs dispersed along the time
period). This dendrogram is based on the Wards clustering and Manhattan distance methods. The heatmap depicts the relative percentage of
each bacterial family for each sample. The relative distance scale for the left y-axis is provided in the lower left corner of the figure. The color scale
for the heatmap is shown in the upper left corner of the figure.
Table 3 Quantitative real-time PCR results expressed as percent (medians and ranges) of microbial genera in the feces
of synbiotic-fed dogs at baseline and after 2 wk of treatment
Genera Synbiotic group (n = 9) Synbiotic group (n = 9) Synbiotic group (n = 9)
% at baseline % after 2 wk of treatment P-value
Lactobacillus spp. 3.71 (0.47-20.15) 16.04 (0.42-26.82) 0.02
Bifidobacterium spp. 0.02 (0.00-0.12) 0.31 (0.02-1.27) 0.01
Enterococcus spp. 0.05 (0.00-0.79) 0.12 (0.03-0.43) 0.95
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Table 4 Quantitative real-time PCR results expressed as percent (medians and ranges) of microbial genera in the feces
of placebo-fed dogs at baseline and after 2 wk of treatment
Genera Placebo group (n = 8) Placebo group (n = 8) Placebo group (n = 8)
% at baseline % after 2 wk of treatment P-value
Lactobacillus spp. 10.07 (0.30-23.18) 10.78 (1.97-28.64) 0.84
Bifidobacterium spp. 0.10 (0.00-0.33) 0.09 (0.00-0.95) 0.47
Enterococcus spp. 0.02 (0.00-0.40) 0.01 (0.00-0.04) 0.19
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be enough prebiotic to modestly increase SCFA produc-
tion [28], but other studies in experimental animals have
suggested that to cause significant increases in the fecal
microbiome of species such as Lactobacillus, that at least
0.5-1% increase in soluble fiber is required [15]. Depend-
ing on the daily caloric intake of the dogs in our study (be-
tween 1700 and 3200 kilocalories) the prebiotic dose (2.5
grams/day) would translate into 0.5-1% of the dry matter
intake which is similar to doses previously used to achieve
microbiome changes [15]. This large prebiotic dose leads
to the premise that the prebiotic in the diet played a part
in the modest microbiome shift in the synbiotic treated
dogs, not the probiotic. The microbiome shift being from
the prebiotic is further supported with the fact that the
only probiotic to survive in the synbiotic preparation was
Enterococcus which showed no increases and is a very
minor part of the microbiome.
Another factor that may have allowed us to observe a
shift in the microbiome was our uniform population of
dogs being fed similarly across the entire trial as well as
the constant exposure to the similar environmental vari-
ables. In experimental colony dogs relatively uniform popu-
lation of microbes in the feces has been observed using
methods other than pyrosequencing [29]. This may be dif-
ferent in household companion animals where the micro-
biome hierarchical clustering shows differences based on
environmental variables more so than on supplemental syn-
biotics provided [21].
A previous study suggested that sled dogs show a more
pronounced alteration in the fecal microbiome after 300
miles of racing when compared to a group of field trial
Labradors that were in a confined location [30]. Our study
controlled for these variables by having identical kenneling,
activity, feeding practices, and all dogs traveled to races
and trained together; however when examining the den-
drogram it is obvious that there is clustering of cases pri-
marily based on time of sampling. Changes observed were
in all dogs which included significant decreases in Clostri-
diaceae, Erysipelotrichaceae and Eubacteriaceae. Whether
this shift in colonic microbial flora was due to the addition
of a fiber source (soluble or insoluble), or gradual change
in environmental variables such as weather, training pat-
tern, exposure to different environments due to travel and/
or changes in bedding cannot be determined by our studydesign. These changes suggest that future studies examin-
ing microbiome changes over time due to environmental
alterations are warranted.
There was also an apparent synbiotic effect since the
majority of synbiotic dogs in the dendrogram samples
post-treatment cluster together in one area to the middle
left of the dendrogram which is due to an increase in
Lactobacillaceae and Streptococcaceae and decreases in
Clostridiaceae suggesting that the prebiotic may be the
reason for this. Prebiotic in the form of FOS/MOS like
the one in our study have shown that acid producing
bacterial populations such as Lactobacillacae and Bifido-
bateriaceae should all increase with an oligosaccharide
rich diet which we show trends for [15]. Bifidobacteria data
were not generated during our pyrosequencing (which is a
shortcoming of this technique at the time of analysis); how-
ever our quantitative real-time PCR results show a small
population in the fecal microbiome that does increase mod-
estly from baseline to 2 wk after treatment in the synbiotic
group that was not observed in the placebo group.
There was a large variation in overall abundance of
fecal flora represented for certain strains such as Lacto-
bacillus, Enterococcus, Streptococcus, Ruminococcus, and
Fusobacteria spp. This allowed us to examine the micro-
bial families in relation to the total SCFA concentrations
as well as each of the SCFA (acetate, butyrate, and pro-
pionate) independently. There was a modest correlation
between Lactobacillus spp. and overall butyrate concen-
tration based on linear regression analysis when examin-
ing all dogs in the study. Butyrate has been associated
with improved enterocyte health and is a byproduct of
the fermentation of fibers; including prebiotics such as
inulin-type fructans [31]. Unfortunately, we did not ob-
serve an increase in overall SCFA or butyrate concentra-
tions in the feces collected from the synbiotic group.
This may be due to a lack of power and the large magni-
tude of microbiome shift other than just Lactobacillus
spp., particularly since the synbiotic groups showed a rise
in Lactobacillus spp. with a decrease in Rumenococcus
spp. which are both acid producing bacterial populations.
An obvious weakness in our study was our inability to
further differentiate the role of each component of the
synbiotic and it would have been ideal to have both pre-
biotic and probiotic alone fed groups. These studies will
help differentiate the effects of the prebiotic as the sole
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which we suggest is the most significant portion of the
synbiotic based on our present findings. Additionally, fu-
ture experiments should incorporate more frequent cul-
turing of the products administered as well as more
frequent testing of fecal samples, which will ensure via-
bility of probiotic organisms and allow observation of
microbiome shifts over time. Furthermore, the placebo
and synbiotic had other constituents such as B vitamins
and yeast incorporated, though negligible amounts in
general, these components may have influenced the
microbiome in some fashion. Most egregious of these
differences was the addition of thiamine, riboflavin, nia-
cin and pantothenate to the synbiotics which were not
in the placebo. Although we would expect adequate ab-
sorption and elimination of these vitamins through renal
excretion the amount that could have made it to the
colon and its effects on the microbiome cannot be deter-
mined. It should also be noted while this was not a
cross-over design, all dogs were housed together, exer-
cised identically, and exposed to the same food and en-
vironmental variables; therefore the differences between
the groups is most likely due to treatment effect, while
the environmental variables observed were not expected,
making environment a significant factor in host micro-
biome interactions that warrants future investigation.
From a clinical perspective, the most important obser-
vation was that the addition of the placebo or the syn-
biotic did not cause an increase or decrease in overall
fecal consistency over the entire study. This is a pertin-
ent point as this trial used a dose of 5 grams per day
which provided well over 108 of each bacterium as well
as 2.5 grams of prebiotic accounting for between 0.5 to
1% of dry matter intake for each dog. More significant,
we were able to observe a difference in fecal consistency
after 5 weeks of treatment during a presumed conta-
gious outbreak of diarrhea in this kennel of sled dogs.
Remarkably the synbiotic group showed fewer affected
dogs (3/9 synbiotic vs. 4/8 placebo) which was not statisti-
cally significant, but more importantly the synbiotic-fed
dogs had fewer days of diarrhea than placebo-fed dogs.
Though speculative the modest increases in Lactobacillus
in the synbiotic group might have led to increased benefi-
cial SCFA at the level of the gastrointestinal mucosa lead-
ing to improved enterocyte function during the bout of
presumed viral diarrhea leading to hastened recovery.
Conclusions
The efficacy of probiotics, prebiotics and synbiotics in the
veterinary market are not well established when examined
in relationship to disease or stress-induced diarrhea. More
often the use of prebiotic to ameliorate diarrhea is utilized
by veterinary clinicians with a recent increase in probiotic
use due to veterinary approved products inundating themarket. From a clinical perspective our findings support
the use of a synbiotic during contagious diarrhea or dur-
ing times when relative risk (racing season with extensive
kennel-kennel interaction) for transmission of contagious
diarrhea is increased to improve the gastrointestinal re-
covery process.
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